Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pipeline Review: Large Potential Overactive Bladder Population Beckons

Nov 22 2018

• By Emily Hayes

Human Body Organs (Urinary Bladder). 3D

Related Content

Deal Watch: Emergent Strikes Again, Acquiring Adapt And Its Opioid Overdose Drug For $635m

Aug 29 2018

Deal Watch: Gilead’s Immunology Collaboration With Verily Continues Pivot Away From Virology

May 02 2018

Roivant Cuts Jobs, Reallocates Staff As It Prepares To Put New Stars In The Spotlight

Jun 27 2018

Daré Bioscience On Prowl To Fill Gaps In Women's Sexual Health

Mar 02 2018

Allergan gains US FDA nod for Botox in overactive bladder

Jan 19 2013

Deal Watch: Merck KGAA, Pfizer, eFFECTOR Agree To PD-L1/MNK Combo Study In CRC

Jun 27 2017

Related Companies

Johnson & Johnson

Allergan plc

Antares Pharma, Inc.

Daewoong Pharmaceutical Company Ltd.

Pfizer Inc.

UCB S.A.

Novartis AG

Astellas Pharma, Inc.

Roivant Sciences Ltd.

Juniper Pharmaceuticals

Daré Bioscience, Inc.

Sio Gene Therapies, Inc.

Urovant Sciences, Inc.

Ion Channel Innovations, LLC.

Oncternal Therapeutics, Inc.

TARIS Biomedical LLC

Additional Topics

Market Intelligence Research & Development Gynecology & Urology BioPharmaceutical

More from Immunological

More from Therapy Areas

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window